Paragon Capital Management Ltd reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 8.9% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 6,745 shares of the healthcare product maker’s stock after selling 657 shares during the quarter. Paragon Capital Management Ltd’s holdings in Abbott Laboratories
0 Comments
The stock market was locked in a narrow range last week as the rally attempts were met with selling. The reaction to a slightly hotter-than-expected CPI report on Thursday was positive but did not last long as concerns grew over the implications of changing global interest rate policies. It appeared that the ECB’s comments about
0 Comments
Electric vehicles (EVs) are undoubtedly the future of transportation. However, EVs still comprise around 1% of the roughly 250 million vehicles on U.S. roads today. This means there’s massive growth potential ahead, as the world transitions away from gas-powered cars over the coming decades. Indeed, no one should be surprised that several pure-play EV stocks
0 Comments
In this article CTLT Follow your favorite stocksCREATE FREE ACCOUNT Rows of glass vials in a biologics laboratory in Sweden. Photographer: Mikael Sjoberg/Bloomberg Bloomberg Creative | Bloomberg Creative Photos | Getty Images Company: Catalent (CTLT) Business: Catalent develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The
0 Comments
In a volatile market, growth stocks can offer tremendous upside for investors willing to stomach some risk. While many high-flying growth names have seen sizable corrections in 2022, the long-term growth narratives for many of these companies remain intact. As the macroeconomic environment improves in 2023 and beyond, some of the most beaten-down growth stocks
0 Comments
High Net Worth Advisory Group LLC bought a new position in shares of Advanced Micro Devices, Inc. (NASDAQ:AMD – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,881 shares of the semiconductor manufacturer’s stock, valued at approximately $214,000. A
0 Comments
General Motors assembly workers picket outside the General Motors Bowling Green plant during the United Auto Workers national strike in Bowling Green, Kentucky, October 10, 2019. Bryan Woolston | Reuters Check out the companies making headlines before the bell. KeyCorp — The Cleveland-based regional bank rose almost 2% premarket after Piper Sandler said the shares
0 Comments
Oracle (NYSE:ORCL – Free Report) had its price target decreased by Barclays from $150.00 to $147.00 in a research note issued to investors on Tuesday, Marketbeat.com reports. Barclays currently has an overweight rating on the enterprise software provider’s stock. Several other research analysts have also commented on the company. Piper Sandler restated an overweight rating
0 Comments
GM workers with the UAW Local 2250 union strike outside the General Motors Wentzville Assembly Plant in Wentzville, Missouri, Sept. 15, 2023. Michael B. Thomas | Getty Images Check out the companies making headlines in midday trading. General Motors, Ford, Stellantis — Shares of Ford was near flat, while General Motors gained 0.9% and Stellantis
0 Comments
Sometimes, I’ll root for an underdog. However, I just can’t get behind electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID) in 2023. LCID stock has been a poor performer and could easily continue to lose value this year. I’m not the only commentator who’s concerned about Lucid Group’s future prospects. As we’ll see, at least one expert
0 Comments
Glassy Mountain Advisors Inc. purchased a new stake in The Walt Disney Company (NYSE:DIS – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 24,430 shares of the entertainment giant’s stock, valued at approximately $2,181,000. A number of other institutional
0 Comments